Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Because of COVID-19, HIV testing nationwide has plummeted as much as 70%.
Only 46% can trace the source of their infection—usually a family member or a coworker.
Can this HIV prevention strategy overcome mistrust and fear among marginalized communities?
Here’s how to do it.
A greater proportion of this population than previously thought could stand to benefit from pre-exposure prophylaxis.
Be #HepAware2020 and learn the ABCs of viral hepatitis.
#NAPIHAAD hopes to break down one of the biggest barriers to discussing HIV among these communities: stigma.
A clinical trial compared injectable cabotegravir given every eight weeks versus daily Truvada for HIV prevention.
The updated symptom list includes muscle pain, sore throat and loss of taste or smell.
The Centers for Disease Control and Prevention estimates that about 36,400 people contracted HIV in 2018.
Experts recommend that everyone should wear cloth face masks in public.
The CDC has issued a report detailing considerations for clinicians prescribing PrEP for this population.
A rundown of POZ’s reporting on the 2020 Conference on Retroviruses and Opportunistic Infections
This includes progestin-only injectable contraception and intrauterine devices.
A study of young transgender and gender-nonconforming youth found there are many ways adults can provide them more support.
People in their 20s and 30s now account for more than a third of newly reported chronic hep C.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.